Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Share Us

ICABB 2019 - 2019 International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2019)--Ei Compendex and Scopus

View: 660

Website | Edit Freely

Category Advanced Bioinformatics;Biomedical Engineering

Deadline: October 25, 2019 | Date: December 19, 2019-December 21, 2019

Venue/Country: Seoul, South Korea

Updated: 2019-09-30 18:13:50 (GMT+9)

Call For Papers - CFP

2019 International Conference on Advanced Bioinformatics and Biomedical Engineering (ICABB 2019) will be held in Seoul National University, Seoul, South Korea during December 19-21, 2019.

Conference Website:

ICABB 2019 Shining Points:

1. Publication: Accepted papers can be published in International Conference Proceedings and indexed by Ei Compendex and Scopus, or International Journal of Pharma Medicine and Biological Sciences (IJPMBS, ISSN: 2278-5221).

2. Academic Visit will be arranged on December 21, 2019.

Conference Venue

Building. 25-1, College of Natural Sciences, Seoul National University

Addr.: Building. 25-1 College of Natural Science, Seoul National University 1 Kwanak-ro Kwanak-gu Seoul, 08826 South Korea

Submission and Contact Methods

Submission Methods:


Tel: +852-3500-0137 (Hong Kong)/+86-28-86528465 (China)

Conference Specialist: Ms. Lulu Liang

ICABB 2019 can provide a platform for academic communication in Bioinformatics, Biomedical Engineering and related areas. For more conference information, please visit the conference website:

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.